Day: June 21, 2022

Tekno Point’s new CX Development Center inaugurated by Adobe India MD

Tekno Point’s new facility in Mumbai will further focus on helping customers accelerate their digital and experience transformation initiatives. MUMBAI, India, June 21, 2022 /PRNewswire/ — Tekno Point, an Award-winning Digital Experience Partner, on Thursday inaugurated its latest CX Development Center located in Mumbai, further reinforcing its position as one of the largest Adobe Experience Manager […]

Rise in Insider Threats Remains a Major Security Risk across Singaporean Enterprises, Says Research

Post-pandemic IT landscape introduces new vulnerabilities unaddressed by current security monitoring tools and frameworks SINGAPORE, June 21, 2022 /PRNewswire/ — Halodata, a leading regional provider of information security solutions has released its latest research report ‘Insider Threat Report 2022-Singapore Edition’, highlighting a number of key trends on insider threats across Singaporean enterprises. A first of its […]

Rider Dome to feature its revolutionary rider safety system in Giken Mobility’s Iso-branded Electric Motorcycles

Giken Mobility and Rider Dome teams, alongside Iso UNO-X SINGAPORE, June 21, 2022 /PRNewswire/ — Rider Dome, a Singapore startup providing motorcyclists with real-time alerts against critical threats on the road, is pleased to announce that it has recently partnered with Giken Mobility Ltd (“Giken Mobility”), the exclusive global licensee and manufacturer of the Italian […]

Innovent and Lilly Jointly Announce the Approval of TYVYT® (sintilimab injection) by China NMPA in Combination with Chemotherapy as First-Line Treatment for Esophageal Squamous Cell Carcinoma

SAN FRANCISCO, INDIANAPOLIS and SUZHOU, China, June 21, 2022 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, autoimmune, metabolic, ophthalmology and other major diseases, and Eli Lilly and Company (“Lilly”, NYSE: LLY) today announced that the Center for Drug […]

Therorna completes Series A financing to accelerate pipeline development and clinical transformation of circRNA-based platform

BEIJING, June 21, 2022 /PRNewswire/ — Therorna Inc., a China-based biotech company specialized in the development of cutting-edge circular RNA (or circRNA) technology-based new vaccines and therapies, announced the completion of a US$42 million Series A financing round. The round was co-led by a well-known industrial investment firm and MSA Capital, with participation from Sherpa Healthcare […]

Back To Top